A. I. Vogel, Preparatyka organiczna (WNT Warszawa,), p. Zielińska J., Makowski M., Maj K., Liwo A., Chmurzyński L.() Anal. A.I. Vogel. Preparatyka Organiczna, WNT, Warszawa (), p. F.V. Lovecchio, E.S. Gore, D.H. Bush. J. Am. Chem. Soc., 96 (), p. Soc. (), p. A.I. Vogel. Preparatyka Organiczna W.N.T. Warszawa ( ), p. C.G. Hatchard, C.A. Parker. Proc. Roy. Soc., A (), p.

Author: Gogrel Yozshuzahn
Country: Kosovo
Language: English (Spanish)
Genre: Travel
Published (Last): 24 May 2015
Pages: 439
PDF File Size: 5.59 Mb
ePub File Size: 13.35 Mb
ISBN: 347-4-63719-116-9
Downloads: 66580
Price: Free* [*Free Regsitration Required]
Uploader: Malazragore

Suitable pharmaceutically acceptable cations include alkali metal e. U, last updated Jul. Compound was prepared using the general procedure described above with respect to compound 14, but 2-amino-4,5-difluoro-benzoic acid was substituted for organiczn acid in step A, 2-tert-butoxycarbonylamino-propionic acid 2,5-dioxopyrrolidinyl ester was substituted for 2-benzyloxycarbonylaminobutyric acid 2,5-dioxo-pyrrolidinyl ester in step B, and the alternate procedure TFA deprotection was used in step C.

Purification of the orgainczna by column chromatography afforded the product as a yellow solid. Oncology Biology Physics 60 1: In some embodiments, step a is performed at a temperature between 0 and 45 degrees Celsius, between 15 and 40 degrees Celsius, or between 20 and 30 degrees Celsius.

Although a propargyl functional group is exemplified, the method illustrated in Procedure E is applicable to many known functional groups. The column was washed extensively with Buffer A, and eluted with a linear gradient of mM imidazole. The filtrate was organiiczna to yield compound 6 as a yellow solid.

In preferred embodiments, the S-enantiomer of the compounds are utilized in the present methods.

Preferred carriers for parenteral administration are physiologically compatible buffers such as Hanks’s solution, Ringer’s solution, or physiologically buffered saline. To illustrate, reperfusion injury occurs at the termination of cardiac bypass procedures or during cardiac arrest when the heart, once prevented from receiving blood, begins to reperfuse. A compound of formula 18 1.

The agents also can be used in vivo as a prophylactic to prevent aberrant cell proliferation or the manifestation of symptoms associated therewith. A mL, prepsratyka, round bottomed flask equipped with a magnetic stirrer and a reflux condenser was purged with nitrogen and charged with compound mg, 0.


The aqueous layer was extracted with additional dichloromethane mLand the combined organic layers were washed with water 50 mL and brine 50 mL. The compounds of the present invention can be prepared by the following methods. It is expressed at high levels in lymphocytes and lymphoid tissues, suggesting that the protein might play a role in PI 3-kinase-mediated signaling in the immune system.

In some embodiments, R 1 is F or Cl. Procedure E provides an additional alternative method of preparing compounds with a variety of side chains appended to the linker between the quinazolinone and purine rings of the inventive compounds. Also included in this definition orgamiczna ammonium and substituted or quaternized ammonium salts.

Compounds of the present disclosure include separable rotational isomers, or atropisomers. Compound 79 is shown below. In some embodiments, step a includes combining a compound of formula 2 or a salt thereof and a compound of formula 3 or a salt thereof with a dehydrating agent and a base.

Accordingly, the compounds of the invention advantageously permit treatment of individuals having an inflammatory condition where leukocytes are found to be accumulating at the site of insult or inflamed tissue.


As shown below, compounds of the present invention inhibit osteoclast function in vitro. Anti-fibrotic agents and methods for inhibiting the activity of lysyl oxidase in-situ using adjacently positioned diamine analogue substrates.

Human neutrophils are obtained as described above, and resuspended in RPMI organifzna supplemented with 0. European Search Report dated Jun. Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents. Office Action dated Jul. A mL, one-neck, round bottomed flask equipped with a magnetic stirrer was charged with 6-bromopurine In some embodiments, the compound of formula 5 is synthesized as the free base, whereas in other embodiments, the compound of formula 5 is synthesized as a salt.

There was a problem providing the content you requested

In some embodiments, n is 1, 2, or 3; and each R 5 is independently selected from a group consisting of methyl, F, and Cl. Column chromatography of the resulting residue yielded intermediate compound 12 as a white solid. In other embodiments, the compounds of the invention exhibit IC 50 values from about 0. Compound 52 is shown below.


Acid addition salts may be prepared from inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, a.j.vogel acid, phosphoric acid, and the like.

Preparatyka organiczna vogel pdf download

The resulting mixture was stirred for 5 min, preparztyka methyl iodide mg, 3. Wydanie the viscosity of glaze as a function of temperature, using Vogel — Fulcher — Tammann. Alternatively, superoxide release can be stimulated by formyl-Met-Leu-Phe fMLP or other peptides blocked at the N-terminus by formylated methionine.

Compound 54 is shown below. The process of claim 2wherein step c further comprises a solvent selected from the group consisting of acetonitrile, methanol, ethanol, isopropanol, n-propanol THF, and toluene. For example, Berge et al. Compound 85 was prepared using the general procedure described above with respect to compound 14, but 2-benzyloxycarbonylamino-pentanoic acid 2,5-dioxo-pyrrolidinyl ester was substituted for 2-benzyloxycarbonylaminobutyric acid 2,5-dioxo-pyrrolidinyl ester in step B, and 2-aminobromopurine was substituted for 6-bromopurine in step D.

These methods comprise determining the reference inhibitory amount of the compounds in an in vitro biochemical assay, in an in vitro cell-based assay, or in an in vivo assay. The protein profile of the enzyme complex during heparin chromatography corresponded to that of lipid kinase activity.

In some cases, it can be desirable to couple the compounds to a moiety that can target the compounds to bone. The process of claim 18wherein step a further comprises a step of combining a base selected from the group consisting of pyridine, 4-dimethylaminopyridine, triethylamine, isopropylethylamine, imidazole, DABCO, DBU, 2,6-lutidine, and N,N-diisopropylethylamine.

Author: admin